REGULATED PATHWAYS. CONTROLLED SUPPLY.
Unapproved medicine access, global sourcing and controlled supply for New Zealand.
Every stage. Every step. One patient is waiting.
HL Pharma is the independent Australian partner for global medicine sourcing, Section 29 supply coordination, Managed Access Programmes, early and post-clinical trial supply, and temperature-controlled supply into New Zealand through appropriately licensed local partners.
Many medicine access requirements involve separate providers for sourcing, regulatory coordination, importation, storage and logistics. HL Pharma brings these functions together through verified global sourcing across more than 15 countries, temperature-controlled handling and coordinated supply into New Zealand through licensed import and distribution partners.
Our services
Watch our 2-minute overview
INTEGRATED PHARMACEUTICAL SERVICES ACROSS NEW ZEALAND AND THE APAC REGION
HL Pharma provides one point of coordination across international medicine sourcing, Australian depot services, export supply, New Zealand medicine access pathways and onward distribution through appropriately licensed New Zealand partners. HL Pharma-managed activities are documented and governed through our ISO 9001:2015-certified quality management system.
Where New Zealand regulatory, import or local distribution expertise is required, we work with trusted specialist partners to ensure each product is correctly handled, documented and supported throughout its supply pathway.
UNAPPROVED MEDICINES & GLOBAL SOURCING:
Global sourcing of unapproved, hard-to-source and specialist medicines for New Zealand, including named-patient supply coordination under Section 29, subject to prescriber and import requirements.
MANAGED ACCESS PROGRAMMES:
Operational support for sponsor-led Managed Access Programmes, including global sourcing, export and import coordination, temperature-controlled handling, inventory management and controlled supply into New Zealand through licensed local partners.
EARLY & POST-CLINICAL TRIAL SUPPLY:
Continuity of medicine access before, during and following a clinical trial, including early access, extension, rollover and post-clinical trial supply arrangements.
CRITICAL, COMPASSIONATE & SHORTAGE SUPPLY:
Responsive global sourcing when an essential medicine is unavailable, discontinued, affected by shortage or required for compassionate access in New Zealand.
VETERINARY MEDICINE SUPPLY:
HL Pharma can supply medicines for veterinary use in New Zealand, provided the appropriate local permits are in place.
TRAVEL MEDICINE SUPPLY:
Specialist sourcing of travel vaccines and medicines for New Zealand healthcare providers, including Section 29 supply coordination where the relevant requirements are met.
Behind every unapproved medicine, every post-trial access programme, every shortage that needs solving, one patient is waiting. HL Pharma was built so that patient doesn’t wait.
We protect your product’s integrity, support your brand, and deliver pharmaceutical services, storage, and distribution with the precision and care your business depends on.
Matt Hayward, Founder and Director
Inspection-ready quality systems, built into every stage.
HL Pharma operates within an ISO 9001:2015-certified quality management system designed to support product integrity, traceability, document control and audit readiness. Our Australian depot processes are aligned with Good Distribution Practice principles and applicable Australian Good Wholesaling Practice requirements, supporting controlled pharmaceutical storage, export supply and regulated medicine access pathways.
YOUR PARTNER FOR PHARMACEUTICAL SERVICES
Contact HL Pharma to discuss medicine sourcing, supply, distribution or regulatory requirements for New Zealand.
We support healthcare professionals and pharmaceutical organisations with licensed and unapproved medicines, temperature-controlled handling and pharmaceutical logistics. We typically respond within one business day. Please provide enough detail for us to direct your enquiry appropriately.
